PathMap Literature Based Discovery Engine

Share your Discovery:

Guaranteed to find unpublished literature based discoveries.

Clear Search

Experiment #00000138

Dietary butyrate from resistant starch may synergize with sulforaphane-driven Nrf2 activation and spermidine-mediated FAM134B ER-phagy in order to restore astrocytic EAAT2 membrane trafficking and potentially clear synaptic glutamate excitotoxicity in neurodegeneration. (Literature Based Discovery)

Starch, Resistant _gates_from_starch__resistant Butyrate _gates_to_butyrate _gates_from_butyrate NF-E2-Related Factor 2 _gates_to_nf_e2_related_factor_2 Sulforaphane _gates_from_sulforaphane Spermidine
View Results
Experiment #00000129

COPD Dietary Idea: According to PubMed literature, he following lunchtime meal plan provides nutrients needed for production and regulation of tryptophan and 3-IPA and may help reduce COPD flare-ups, while also providing mucosal support for clearance of debris from the lungs: -2x slices sourdough bread, lightly spread with extra virgin olive oil, garlic, and ginger, with 2x slices of cooked turkey and spinach, with nutritional yeast and hi-maize corn starch mixed into the EVOO (for mucosal system support) -a spinach-based salad with 1 Tbsp EVOO -3 oz pomegranate juice mixed with 3 oz cherry juice

Tryptophan _gates_from_tryptophan Gut Microbiota _gates_to_gut_microbiota _gates_from_gut_microbiota Indolepropionic Acid _gates_to_indolepropionic_acid IPA _gates_from_ipa Lung
View Results
Experiment #00000113

COPD Related Alveoli and Lung Microbiome Axis Restoration Hypothesis: The use of 'pre-digested' (fermented) plant-based nutritional additives as a means to circumvent the bioavailability paradox in patients with gut dysbiosis, effectively using botanical matrices as drug-delivery vehicles. Nucleotide supplementation may enhance the ability of A. muciniphila to modulate gut mucosal barrier integrity in hyperuricemia patients. *Akkermansia* possesses unique enzymes (β-N-acetylhexosaminidases) that allow it to colonize the mucosal layer and participate in mucin degradation.

Fermentation _gates_from_fermentation Bioavailability _gates_to_bioavailability _gates_from_bioavailability Homeostasis _gates_to_homeostasis Plant Preparations _gates_from_plant_preparations Probiotics
View Results
Experiment #00000091

Context:A patient is brought into a remote aid station after an explosion inside a covert manufacturing facility. They have a known concussive blast injury, moderate skin irritation, and potential unknown chemical inhalation.Patient Clinical Presentation:Physical Trauma: Grade 2 concussion (confusion, mild disorientation, reactive pupils).Dermatological: Superficial skin burning and blistering across the forearms. The skin smells faintly of burnt almonds or cut grass.Respiratory/Systemic: Shortness of breath, mild tachypnea, and sudden, severe muscle twitching (fasciculations) that began 10 minutes post-exposure.Operational Constraint:Standard advanced diagnostics are unavailable. The primary treatment kit contains standard trauma items, atropine/pralidoxime (2-PAM) autoinjectors, sodium thiosulfate, hydroxycobalamin, and basic field-expedient wellness supplies.Scan Instructions:Run a single scan over the medical and toxicological corpus to map this multi-system presentation. Provide the following outputs using Veridical Enforcement:Differential Toxin Ranking: Based on the combination of blast concussion, skin burning, and the specific onset of muscle twitching vs. scent clues, identify and rank the top two most likely overlapping chemical exposure pathways.The Dynamic Counter-Response (The "If/Then" Fork): Map the exact treatment-response trap. If I suspect Toxin A and administer standard Countermeasure X (e.g., an anticholinergic like atropine), but the patient’s fasciculations instantly stop while their blood pressure dangerously spikes and pupils violently dilate, what secondary hidden pathway does this reaction reveal?Veridical Contraindications: Explicitly cite the exact physiological mechanisms and PubMed-grounded parameters where standard concussion management (e.g., specific fluid resuscitation volumes or sedatives) directly exacerbates the cellular hypoxia or neurotoxicity caused by the suspected chemical inhalants. Do not hallucinate or approximate citations.

Blast Injuries _gates_from_blast_injuries Toxicology _gates_to_toxicology Fasciculations _gates_from_fasciculations Cholinesterase Inhibitors _gates_to_cholinesterase_inhibitors
View Results
Experiment #00000073

Can botulinum toxin A (BTX-A) be repurposed from cosmetic/spasticity applications in order to treat oculomotor palsy and have utilization with endoscopic endonasal approaches to skull base tumors to protect cranial nerves?

Botulinum Toxins, Type A _gates_from_botulinum_toxins__type_a Muscle Relaxation _gates_to_muscle_relaxation _gates_from_muscle_relaxation Neuroprotection _gates_to_neuroprotection Oculomotor Nerve Diseases _gates_from_oculomotor_nerve_diseases BTX-A
View Results
Experiment #00000063

What specific structural modifications to the pyrrolidinone scaffold led to improved potency against SARM1 compared to earlier inhibitor classes?

Pyrrolidinones _gates_from_pyrrolidinones SARM1 _gates_to_sarm1 Sterile Alpha and TIR Motif Containing 1 _gates_from_sterile_alpha_and_tir_motif_containing_1 Axonal Degeneration _gates_to_axonal_degeneration Molecular Structure _gates_from_molecular_structure
View Results